Cardiomyocyte regeneration after infarction: changes, opportunities and challenges

Area of Science:

• Cardiology
• Regenerative Medicine
• Molecular Biology

Background:

• Myocardial infarction (MI) is a leading cause of death, historically considered irreversible due to limited cardiomyocyte regeneration in adult mammals.
• Recent evidence suggests that cardiomyocytes possess latent regenerative capabilities under specific physiological or experimental conditions.
• Understanding these capabilities is crucial for developing novel treatments for heart damage.

Purpose of the Study:

• To comprehensively review the current research on post-infarction cardiomyocyte regeneration.
• To elucidate the underlying mechanisms, influencing factors, and therapeutic strategies for promoting heart regeneration.
• To identify specific pathways and molecular targets for future therapeutic interventions.

Main Methods:

• Literature review and synthesis of recent research findings on cardiomyocyte biology and cardiac repair.
• Analysis of studies investigating the cellular and molecular mechanisms of cardiomyocyte proliferation and survival post-MI.
• Evaluation of preclinical and clinical data on therapeutic approaches aimed at enhancing cardiac regeneration.

Main Results:

• Adult cardiomyocytes exhibit a greater regenerative potential than previously assumed, particularly following injury.
• Key signaling pathways and molecular targets involved in cardiomyocyte cell cycle re-entry and survival have been identified.
• Various factors, including age, injury type, and microenvironment, influence the extent of regeneration.

Conclusions:

• Cardiomyocyte regeneration offers a promising therapeutic strategy for treating myocardial infarction and heart failure.
• Further research into specific regenerative pathways and targeted interventions is warranted.
• Overcoming challenges in translating regenerative approaches is essential for clinical application in cardiovascular disease treatment.